C. Tirier
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 5
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- W. Heit (2 shared papers)Brigitte Schlegelberger (2 shared papers)Lanier H. Ayscue (1 shared paper)Beverly S. Mitchell (1 shared paper)J. Schütte (1 shared paper)S. Seeber (1 shared paper)Dirk Strumberg (1 shared paper)Michael Flaßhove (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer (1 paper)The Breast (1 paper)Blood (1 paper)Langenbeck s Archives of Surgery (1 paper)
- Partner nations
- Germany
In The Last Decade
C. Tirier
10 papers receiving 237 citations
Peers
Comparison fields: 5 of 44
- Pathology and Forensic Medicine 150
- Genetics 85
- Oncology 122
- Hematology 44
- Dermatology 15
Countries citing papers authored by C. Tirier
This map shows the geographic impact of C. Tirier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tirier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tirier more than expected).
Fields of papers citing papers by C. Tirier
This network shows the impact of papers produced by C. Tirier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tirier. The network helps show where C. Tirier may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Tirier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside. | 1994 | 59 |
| 2 | 1998 | 48 | |
| 3 | 1996 | 41 | |
| 4 | Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group. | 1996 | 41 |
| 5 | Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. | 1996 | 24 |
| 6 | 1997 | 11 | |
| 7 | 1990 | 10 | |
| 8 | 2012 | 10 | |
| 9 | 2011 | 2 | |
| 10 | 1997 | 2 |
About C. Tirier
C. Tirier is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Genetics and Surgery, having authored 10 papers that have together received 248 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Renal Diseases and Glomerulopathies (2 papers), Abdominal Trauma and Injuries (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Treatment and Pharmacology (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (150 citations), Genetics (85 citations), Oncology (122 citations), Hematology (44 citations) and Dermatology (15 citations). C. Tirier has collaborated with scholars based in Germany. Frequent co-authors include W. Heit, Brigitte Schlegelberger, Lanier H. Ayscue, Beverly S. Mitchell, J. Schütte, S. Seeber, Dirk Strumberg, Michael Flaßhove, Andreas Engert and Norbert Schmitz. Their work appears in journals such as Journal of Clinical Oncology, Cancer, The Breast, Blood and Langenbeck s Archives of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.